Entera Bio Ltd. (ENTX) Free cash flow 2020–2025
Entera Bio Ltd. (ENTX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$7.5MFY2025 · since FY2020: -$10.6M → -$7.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$7.5M | -9.6% |
| FY2024 | -$6.8M | +6.9% |
| FY2023 | -$7.3M | +41.6% |
| FY2022 | -$12.5M | -38.2% |
| FY2021 | -$9.1M | +14.4% |
| FY2020 | -$10.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice